Previous 10 | Next 10 |
Laser Photonics Corporation (LASE) is expected to report for Q2 2024 QuickLogic Corporation (QUIK) is expected to report $0.08 for Q3 2023 Stryve Foods Inc. (SNAX) is expected to report $-1.65 for Q3 2023 Reata Pharmaceuticals Inc. (RETA) is expected to report $-2.15 for Q3 2023 V...
Heartbeam Inc. (BEAT) is expected to report $-0.12 for Q3 2023
HeartBeam (NASDAQ: BEAT) , a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home, today announced the expansion of its scientific advisory board (“SAB”) to include sever...
Company Adds Leading Cardiologists to Provide Strategic Insights HeartBeam, Inc . (NASDAQ: BEAT), a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (VECG) platform for patient use at home, allowing for the creation of...
HeartBeam (NASDAQ: BEAT) , a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home, today announced that the United States Patent and Trademark Office has granted a new patent on its VE...
New Patent Extends Intellectual Property Footprint for Company’s Groundbreaking Technology in Large ECG Patch Monitor Market HeartBeam, In c. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only credit card-size, portable 3D-vector electrocar...
2023-10-31 10:00:02 ET More on Health Care Select Sector SPDR Stocks to watch in the Health Care sector as earnings close in BofA reports 10th consecutive week of equity inflows For further details see: Sarepta Therapeutics, Petmed Express among healthcare movers
HeartBeam, Inc . (NASDAQ: BEAT), a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (VECG) platform for patient use at home, allowing for the creation of rich data for AI, will hold a conference call on Tuesday November 14, 2023 a...
Implicity Expands Senior Leadership Team with New U.S. Chief Commercial Officer PR Newswire Medical device industry veteran, Jon Hunt , will lead the next phase of growth for Implicity as demand for remote cardiac monitoring and data management solutions soars CA...
HeartBeam (NASDAQ: BEAT) , a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home allowing for the creation of rich data for AI, has appointed two new team leaders. The company announc...
News, Short Squeeze, Breakout and More Instantly...
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has been added to the Russell Microcap(R) Index. The move was effective after market close on June 28, 2024, and is part of FTSE Russell’s annual reconst...
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced that it has been added to the Russell Microcap® Index effective after the market close on June 28, 2024 as part of FTSE Russell...
HeartBeam (NASDAQ: BEAT) , a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced the results of a new study demonstrating that HeartBeam AI combined with vectorcardiography (“VCG”) outperformed an expert panel o...